Astera Labs (ALAB) Reiterated at Buy by Stifel After CFO Meeting

Stifel analyst Tore Svanberg reiterated a Buy rating and $260.00 price target on Astera Labs (NASDAQ: ALAB).

The analyst commented, "We recently hosted ALAB’s Mike Tate, former CFO and current Strategic Advisor, and Leslie Green, Head of IR for a series of 1-on-1 investor meetings at Stifel’s Cross-Sector 1-on-1 2026 conference in Boston. The following represents our key takeaways from those conversations, summarized as i) a broadening TAM across its product portfolio; ii) the optical roadmap is a sizable incremental opportunity layered on top of existing TAM quantification, and iii) a healthy demand backdrop with no signs of over-ordering."

For an analyst ratings summary and ratings history on Astera Labs click here. For more ratings news on Astera Labs click here.

Shares of Astera Labs closed at $363.54 yesterday.

You May Also Be Interested In

• Stifel Canada Starts BlackBerry (BB) at Buy
• Mizuho Downgrades Apogee Therapeutics Inc (APGE) to Neutral
• Backblaze Inc (BLZE) PT Raised to $14 at Citizens on CRWV Deal Announcement